arrow
M

Michel Vidal

AP-HP
H指数:34
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients

利妥昔单抗诱导和维持方案在抗中性粒细胞胞浆抗体(ANCA)相关性血管炎中的比较:真实世界患者中ANCA和免疫球蛋白G水平的药代动力学/药效学建模

2025-11-030
OAAI
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
2024-03-260
PRE
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
2024-01-251
PRE
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance Therapy

利妥昔单抗维持治疗期间血浆利妥昔单抗浓度与抗中性粒细胞胞浆抗体相关血管炎复发风险的关系

2023-08-133
PRE
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

奥希替尼在晚期非小细胞肺癌患者中的暴露-反应分析

2022-09-0117
OAAI
VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
2019-07-0124
OAAI